Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mitochondrial proteins function as essential regulators in apoptosis. Here, we show that mitochondrial
adenylate kinase 2
(
AK2
) mediates mitochondrial apoptosis through the formation of an
AK2
-FADD-caspase-10 (AFAC10) complex. Downregulation of
AK2
attenuates etoposide- or staurosporine-induced apoptosis in human cells, but not that induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) or Fas ligand (FasL). During intrinsic apoptosis,
AK2
translocates to the cytoplasm, whereas this event is diminished in Apaf-1 knockdown cells and prevented by Bcl-2 or Bcl-X(L). Addition of purified
AK2
protein to cell extracts first induces activation of caspase-10 via FADD and subsequently caspase-3 activation, but does not affect
caspase-8
. AFAC10 complexes are detected in cells undergoing intrinsic cell death and
AK2
promotes the association of caspase-10 with FADD. In contrast, AFAC10 complexes are not detected in several etoposide-resistant human tumour cell lines. Taken together, these results suggest that, acting in concert with FADD and caspase-10,
AK2
mediates a novel intrinsic apoptotic pathway that may be involved in tumorigenesis.
...
PMID:AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. 1795 61